Abstract

BackgroundThe β2-adrenergic receptor (β2AR) is a primary target for medications used to treat asthma. Due to the low abundance of β2AR, very few studies have reported its localization in tissues. However, the intracellular location of β2AR in lung tissue, especially in airway smooth muscle cells, is very likely to have a significant impact on how the airways respond to β-agonist medications. Thus, a method for visualizing β2AR in tissues would be of utility. The purpose of this study was to develop an immunofluorescent labeling technique for localizing native and recombinant β2AR in primary cell cultures.MethodsA panel of six different antibodies were evaluated in indirect immunofluorescence assays for their ability to recognize human and rat β2AR expressed in HEK 293 cells. Antibodies capable of recognizing rat β2AR were identified and used to localize native β2AR in primary cultures of rat airway smooth muscle and epithelial cells. β2AR expression was confirmed by performing ligand binding assays using the β-adrenergic antagonist [3H] dihydroalprenolol ([3H]DHA).ResultsAmong the six antibodies tested, we identified three of interest. An antibody developed against the C-terminal 15 amino acids of the human β2AR (Ab-Bethyl) specifically recognized human but not rat β2AR. An antibody developed against the C-terminal domain of the mouse β2AR (Ab-sc570) specifically recognized rat but not human β2AR. An antibody developed against 78 amino acids of the C-terminus of the human β2AR (Ab-13989) was capable of recognizing both rat and human β2ARs. In HEK 293 cells, the receptors were predominantly localized to the cell surface. By contrast, about half of the native rat β2AR that we visualized in primary cultures of rat airway epithelial and smooth muscle cells using Ab-sc570 and Ab-13989 was found inside cells rather than on their surface.ConclusionAntibodies have been identified that recognize human β2AR, rat β2AR or both rat and human β2AR. Interestingly, the pattern of expression in transfected cells expressing millions of receptors was dramatically different from that in primary cell cultures expressing only a few thousand native receptors. We anticipate that these antibodies will provide a valuable tool for evaluating the expression and trafficking of β2AR in tissues.

Highlights

  • The β2-adrenergic receptor (β2AR) is found in several cell types within the lung where it mediates a number of important functions including relaxation of airway smooth muscle [1,2,3], activation of ion and fluid transport in epithelial cells [4], inhibition of mediator release from mast cells [5], stimulation of surfactant secretion in alveolar type 2 cells and stimulation of mucus secretion by submucosal glands [6,7,8]

  • The analysis indicated that 43.7 ± 9.9% of the total signal for β2AR was intracellular in primary cultures of rat airway epithelial cells

  • Immunofluorescence and immunohistochemical methods are of value in studying trafficking and regulation of the β2AR because they can be used in the context of the whole tissue

Read more

Summary

Introduction

The β2-adrenergic receptor (β2AR) is found in several cell types within the lung where it mediates a number of important functions including relaxation of airway smooth muscle [1,2,3], activation of ion and fluid transport in epithelial cells [4], inhibition of mediator release from mast cells [5], stimulation of surfactant secretion in alveolar type 2 cells and stimulation of mucus secretion by submucosal glands [6,7,8]. The β2AR in smooth muscle cells is thought to be the principal target for the β-agonist medications used to treat asthma and other obstructive airway diseases. The problem of tolerance may pose risks to patients using both short-acting (SABA) and long-acting beta-agonists medications (LABAs). It is thought that this clinical tolerance is the result of cellular mechanisms used to attenuate the cellular responses to β-agonist activation of β2AR. The β2-adrenergic receptor (β2AR) is a primary target for medications used to treat asthma. The intracellular location of β2AR in lung tissue, especially in airway smooth muscle cells, is very likely to have a significant impact on how the airways respond to β-agonist medications. The purpose of this study was to develop an immunofluorescent labeling technique for localizing native and recombinant β2AR in primary cell cultures

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call